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Prevalence and etiology of anemias in the adult Turkish
population
Ramazan MEMİŞOĞULLARI1, Hayriye AK YILDIRIM1, Taner UÇGUN1, Melih Engin ERKAN2,
Cemalettin GÜNEŞ3, Mesut ERBAŞ4, Adem GÜNGÖR5, Mehmet Emin YANIK6

Aim: Anemia is common in the general population and one of the most frequently observed nutritional deficiency
diseases in the world today. The aim of this study was to investigate the prevalence and etiology of anemias in a large
cohort representing the Turkish nation.
Materials and methods: The study population comprised 2187 subjects. Serum iron, iron binding capacity, ferritin,
vitamin B12, and folic acid analyses were conducted with autoanalyzers using commercial kits.
Results: A total of 565 (25.8%) subjects (423 females and 142 males) were diagnosed as anemic. The prevalence of
anemia was 30.0% in female and 18.2% in male participants. Iron deficiency was present in 26.7%. Two hundred sixtyfive (46.9%) had microcytic, 297 (52.6%) had normocytic, and 3 (0.5%) had macrocytic anemia. Although 29.3% had
B12 and 2.2% had folic acid deficiency, in only 3 cases was macrocytosis determined.
Conclusion: The results of the present study showed that the prevalence of anemia in Turkey is higher than that reported
in previous studies. Moreover, mean corpuscular volume is not always an available guide, and should not be used alone
in the diagnosis of megaloblastic anemia, and it should be kept in mind that iron deficiency can cover macrocytosis.
Key words: Anemia, iron deficiency, vitamin B12 deficiency, folic acid deficiency, mean corpuscular volume

Introduction
Anemia is a public health problem that affects
populations in both undeveloped and developing
countries (1-4). The impact of anemia on the physical
and psychological health status is well known.
Anemia is a disorder characterized by a blood
hemoglobin concentration lower than the defined
normal level, and is usually associated with a decrease
in the circulating mass of red blood cells (1,2). The
World Health Organization (WHO) suggests that the

serum hemoglobin concentration should be <13 mg/
dL in males and <12 mg/dL in females and serum
hematocrit should be <39% in males and <36% in
females for the diagnosis of anemia (4). Anemia
may result from decreased generation of red blood
cells or from their premature destruction, or from
loss through chronic blood loss or hemorrhage (4).
Treatment of anemias in the early period prevents
permanent damage; therefore early diagnosis of
anemia is important. In order to combat anemia,
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epidemiologic data on anemia is vital. On the other
hand, deficiency of vitamin B12 or folic acid generally
causes macrocytic anemia. However, many subjects
with vitamin B12 or folic acid deficiency do not have
macrocytosis (5-7). The prevalence, incidence, and
etiology of anemias have not been extensively studied
in the general population in Turkey. The aim of this
study was to investigate the prevalence and etiology
of anemias and to investigate the relation of vitamin
B12, folic acid, or iron deficiencies with macrocytosis
or microcytosis in a large cohort representing the
Turkish nation.
Materials and methods
Study population
The MELEN Study is a prospectively designed survey
on the prevalence of cardiometabolic risk factors in
Turkish adults. The baseline visits were carried out
in May and June 2010 and biennial follow-up visits
were planned. The name of the study comes from the
valley in northeast Düzce, Turkey, which is inhabited
by 21,000 people. There is a town (Yığılca) and 39
villages. Health services in the region are provided
by 6 family physicians, each responsible for almost
2500 adults. The study was conducted in May and
June 2010 in the Social Health Center located in
the town center. Four hundred subjects from each
family physician representatively stratified for sex,
age, and rural-urban distribution were randomly
chosen and invited to participate in the study. A total
of 2298 (1471 females and 827 males) subjects with
a mean age of 50 (age range 18 to 92) were surveyed.
Data were obtained by a questionnaire, physical
examination, and sampling of blood. The study
protocol was approved by the Ethics Committee of
Düzce University and every subject signed a consent
form.
Subjects who refused to give blood samples and
who did not have all the results of anemia parameters
were excluded. Thus 2187 subjects (1407 females and
780 males) were included in the final analysis.
Definitions
Hemoglobin concentration below 13 g/dL in males
and 12 g/dL in females was accepted as anemia
according to WHO recommendations (4). The
diagnosis of iron deficiency was determined by one
of the following conditions:
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a.

Serum ferritin level should be <20 ng/mL.

b.

Serum ferritin level between 20 and 40 ng/
mL and serum iron level <60 μg/dL.

According to mean corpuscular volume (MCV)
subjects with anemia were divided into 3 groups,
being microcytic if MCV was <80 fL, normocytic if
MCV was 80-95 fL, and macrocytic anemic if MCV
was >95 fL, respectively.
Vitamin B12 deficiency was defined as a level of
<200 pg/mL. Folic acid deficiency was defined as a
level of <2 ng/mL (8,9).
A TSH level below 0.35 IU/mL or above 4.5
IU/mL indicated thyroid disease. Decreased renal
function was defined as a serum creatinine level of
>1.4 mg/dL in males and >1.1 mg/dL in females.
All individuals were scored according to meat
consumption as follows: once daily = 1 point; once a
week = 2 points; once a month = 3 points; once a year
= 4 points. Total points and meat consumption are
inversely proportional.
Transferrin saturation index % (TSI%) was
calculated as follows: TSI% = [Serum iron level/total
iron binding capacity (TIBC)] × 100.
Sample collection
Ten milliliters of blood were drawn from the
antecubital vein of each subject by applying minimal
tourniquet force. The first 2 mL of blood, which
was used for the complete blood count, was drawn
into a vacutainer tube containing 0.04 mL of the
7.5% K3 salt of ethylene-diamine-tetraacetic-acid
(EDTA). The remaining 8 mL of blood was drawn
into a vacutainer tube without anticoagulant. These
blood samples were allowed to clot for 20 min prior
to centrifugation. The blood tubes were centrifuged
for 10 min at 1500 × g and were processed within 30
min in place. Sera were aliquoted and divided into
4-6 Eppendorf tubes and shipped within a few hours
on cooled gel packs at 2-5 °C to the Düzce University
Hospital Central Laboratory. Aliquots of the serum
were frozen at −80 °C until analyses.
Biochemical analysis
A complete blood count was performed on the
same day by a CELL-DYN 3700 SL analyzer (Abbott
Diagnostics, Chicago, USA).
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Serum iron, total iron binding capacity, and
ferritin analyses were conducted in 5 batches and were
measured with commercial kits using a Cobas 6000
autoanalyzer (Roche Diagnostics GmbH, Mannheim,
Germany). Intra-assay variability (CV%) was 0.6%
for iron, 2.1% for iron binding capacity, and 1.4% for
ferritin. Inter-assay variability was 1.5% for iron, 3.5%
for iron binding capacity, and 2.2% for ferritin.

Table 1. Biochemical characteristics of anemic group (n = 565).

Serum vitamin B12 and folic acid levels were
measured by Siemens IMMULITE 2000 (Siemens
Healthcare Diagnostics Inc., Flanders, NJ, USA)
competitive chemiluminescent-enzyme immunoassay
method and were conducted in 6 batches. Intra-assay
variability was (CV%) 7.0% for vitamin B12 and 4.0%
for folic acid. Inter-assay variability was 6.0% for
vitamin B12 and 5.2% for folic acid.

Serum vitamin B12 level (pg/mL)

288 ± 142

Serum folic acid level (ng/mL)

8.5 ± 3.9

Sex (females/males)

421/141

Hemoglobin (g/dL)

11.2 ± 1.2

Hematocrit (%)

34.4 ± 4.1

MCV (fL)

78.9 ± 8.3

Quality control of biochemical analyses

Analytes

Mean ± SD

Serum iron level (μg/dL)
Serum ferritin level (ng/mL)

203 ± 184

TIBC (μg/dL)

400 ± 78

TSI (%)

16 ± 9

RDW (%)

15.5 ± 1.9
3

In the laboratory, periodical quality control was
performed to detect errors that affect test results, as
described previously (10).
Statistical analysis
Statistical Package for the Social Sciences version 12
(Chicago, IL, USA) was used for analysis. Descriptive
parameters were shown as mean ± standard
deviation (SD) or in percentages. Two-sided t-tests
and Pearson’s chi-square tests were used to analyze
the differences in means and proportions between
groups. Abnormally distributed variables were
compared using the Mann-Whitney U test. A P value
< 0.05 was considered significant.
Results
In the final analysis 2187 subjects (1407 females and
780 males) were included. A total of 565 (25.8%)
subjects (423 females and 142 males) were diagnosed
as anemic. The prevalence of anemia was 30.0% in
female and 18.2% in male participants. Biochemical
characteristics of the anemic group are shown in
Table 1.
Iron deficiency was present in 151 (26.7%) of the
total anemic subjects (Table 2). Two hundred sixtyfive (221 females, 44 males; 46.9%) of the 565 anemic
subjects had microcytic, 297 (200 females, 97 males;
52.6%) had normocytic, and 3 (2 females, 1 male;
0.5%) subjects had macrocytic anemia, respectively.

61 ± 33

Platelets (10 /μL)
MPV (fL)

267.6 ± 80.6
8.9 ± 1.6

TIBC: total iron binding capacity; TSI: transferrin saturation
index; MCV: mean corpuscular volume; RDW: red cell
distribution width; MPV: mean platelet volume

Taking 90 fL as the cut-off value for MCV, the number
of subjects with macrocytic anemia increased to 121.
Demographic and biochemical differences between
microcytic anemia and normocytic anemia groups
are presented in Table 3. Characteristics of the
normocytic group are shown in Table 4.
Although 29.3% of the anemics had B12 and 2.2%
had folic acid deficiency, only 3 had macrocytosis.
Subjects with anemia were further analyzed
according to vitamin B12 and folic acid levels. Mean
MCV, ferritin, hemoglobin level, TSI%, and age
were not significantly different between the vitamin
B12 deficient and nondeficient groups (78.5 ± 9.3 fL,
198.0 ± 192.6 ng/mL, 11.2 ± 1.1 g/dL, 15.6 (9.8)%,
and 48.7 ± 16.7 years versus 79.1 ± 7.4 fL, 211.2 ±
180.5 ng/mL, 11.2 ± 1.3 g/dL, 16.3 (9.5)%, and 50.7
± 16.8 years, respectively). The differences were
also nonsignificant in groups with folate deficiency
and with normal folate level (80.8 ± 8.4 fL, 257.9 ±
191.0 ng/mL, 11.4 ± 1.2 g/dL, 15.0 (7.7)%, and 49.6 ±
19.7 years versus 78.7 ± 8.2 fL, 203.5 ± 183.9 ng/mL,
11.3 ± 1.2 g/dL, 16.0 (9.3)%, and 50.4 ± 16.6 years,
respectively).
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Table 2. Demographic and biochemical features in iron deficiency and nondeficiency groups.
Anemia with iron deficiency
(n = 151)

Anemia without iron deficiency
(n = 414)

P

129/22

279/135

<0.001

Urban living (n)

23 (15.2%)

63 (15.2%)

0.997

Women in menopause (n)

42 (32.8%)

131 (43.7%)

0.036

The number of abortions

0.8 ± 1.2

0.8 ± 1.0

0.953

The number of births

4.1 ± 2.1

4.7 ± 2.9

0.048

Alcohol addict (n)

2 (1.3%)

7 (1.6%)

0.758

Smoker (n)

20 (13.2%)

40 (9.7%)

0.058

Subjects with chronic disease (n)

66 (43.7%)

191 (46.1%)

0.537

Age (years)

47 ± 16

52 ± 17

0.010

TV watching (h/day)

1.9 ± 1.8

1.2 ± 1.8

0.881

Meat consumption

3.3 ± 0.9

3.1 ± 0.9

0.015

Systolic blood pressure (mmHg)

126 ± 27

127 ± 25

0.711

Diastolic blood pressure (mmHg)

79 ± 14

78 ± 14

0.294

Body mass index (kg/m2)

30 ± 8

29 ± 8

0.067

Heart rate (pulse/h)

73 ±11

72 ± 12

0.748

Depression (n)

50 (33.1%)

69 (16.7%)

0.010

Serum vitamin B12 level (pg/mL)

268 ± 134

294 ± 143

0.091

Serum folic acid level (ng/mL)

8.5 ± 3.8

8.4 ± 3.9

0.838

43 (28.5%)

80 (19.3%)

0.029

2 (1.3%)

10 (2.4%)

0.356

Sex (females/males)

The number of subjects with low vitamin B12
The number of subjects with low folic acid

Discussion
The results of the present study showed that most of
the subjects with anemia that had B12 or folic acid
deficiency were not macrocytic. Although 29.3% of
anemics had B12 deficiency (6.0% of the whole study
population) and 2.2% had folic acid deficiency (0.6%
of the whole study population), macrocytic anemia
was found in only 3 subjects. When anemics were
divided into groups according to MCV, most of the
anemics were found to have normocytic anemia.
Many studies emphasized that patients with B12 or
folic acid deficiency frequently had anemia but did
not have macrocytosis, since megaloblasts were seen
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in the late phase of these vitamin deficiencies (5-7).
These data were concordant with our findings. Mean
corpuscular volume is not always a guide and should
not be used alone in the diagnosis of megaloblastic
anemia. It should be kept in mind that iron deficiency
can cover macrocytosis. As seen in Table 2, in the
current survey 28.5% of iron deficiency anemia had
coexistent vitamin B12 deficiency.
Different ranges of normal values were reported
for vitamin B12 and folic acid in the literature. In the
present study, the authors accepted the lower limit
as 200 pg/mL for vitamin B12 and 2 ng/mL for folic
acid (8,9). The prevalence of vitamin B12 deficiency
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Table 3. Demographic and biochemical differences between microcytic anemia and normocytic anemia group.
Microcytic anemia
(n = 265)

Normocytic anemia
(n = 297)

P

67 (25.3%)

105 (35.4%)

0.010

0

3 (1.0%)

0.252

Hypertension (n)

60 (22.6%)

105 (35.4%)

0.010

Chronic obstructive lung disease (n)

16 (6.0%)

24 (8.1%)

0.365

Diabetes mellitus (n)

26 (9.8%)

40 (13.5%)

0.199

Smokers (n)

30 (11.3%)

30 (10.1%)

0.371

Drug consumption (n)

98 (37.0%)

157 (52.9%)

<0.001

Depression (n)

67 (25.3%)

52 (17.5%)

0.018

Thyroid disease (n)

42 (15.8%)

64 (21.5%)

0.187

Income status (TL*)

800 ± 686

767 ± 565

0.544

TV watching (h/day)

1.93 ± 1.9

1.93 ± 1.9

0.998

The number of abortions

0.8 ± 1.2

0.8 ± 1.0

0.865

The number of births

4.1 ± 2.5

5.0 ± 3.1

0.020

Fasting glucose level (mg/dL)

108 ± 34

114 ± 47

0.750

Serum creatinine level (mg/dL)

0.73 ± 0.2

0.80 ± 0.25

0.010

Decreased renal function

9 (3.4%)

16 (5.4%)

0.227

55 (20.8%)

68 (22.9%)

0.672

Number of subjects with low folic acid

4 (1.5%)

8 (2.7%)

0.342

Serum vitamin B12 level (pg/mL)

281 ± 134

292 ± 146

0.406

Serum folic acid level (ng/mL)

8.4 ± 3.8

8.5 ± 4.0

0.661

Serum iron level (μg/dL)

48 ± 31

71 ± 29

<0.001

Serum ferritin level (ng/mL)

224 ± 199

185 ± 167

0.015

TSI (%)

12.3 ± 8.9

19.3 ± 8.8

<0.001

TIBC (μg/dL)

422 ± 77

381 ± 72

<0.001

Menopause (n)
Chronic renal failure (n)

Number of subjects with low vitamin B12

TIBC: total iron binding capacity;
TSI: transferrin saturation index
*1 TL = $0.55
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Table 4. Biochemical analysis of the normocytic group.
Total
(n = 297)

Females
(n = 97)

Males
(n = 200)

P

11.6 ± 1

12.2 ± 1.1

11.3 ± 0.9

0.010

35 ± 3

37.4 ± 2.8

34 ± 3.3

0.010

White blood cells

6150 ± 1740

6290 ± 1870

6088 ± 1674

0.342

Platelets (103/μL)

256 ± 73

237 ± 76

266 ± 69

<0.001

MPV (fL)

8.7 ± 1.3

8.6 ± 1.4

8.8 ± 1.3

0.373

18.5 ± 1.67

20.8 ± 1.49

17.5 ± 1.74

0.126

381 ± 72

352 ± 64

394 ± 72

<0.001

Serum folic acid level (ng/mL)

8.5 ± 4

8.2 ± 4.5

8.7 ± 3.7

0.295

Serum iron level (μg/dL)

71 ± 30

77 ± 32

68 ± 28

0.023

292 ± 146

313 ± 167

283 ± 135

0.178

54 ± 17

62 ± 13

51 ± 16

<0.001

Hemoglobin (g/dL)
Hematocrit (%)

Serum ferritin level (ng/mL)
TIBC (μg/dL)

Serum vitamin B12 level (pg/mL)
Age (years)

TIBC: total iron binding capacity; MPV: mean platelet volume

was reported as 6.5% in Framingham and 25% in
Dutch studies (8,11) in elderly persons (taking the
lowest normal cut-off as 200 pg/mL). In the Turkish
population, vitamin B12 deficiency prevalence in
elderly subjects was reported as 22.6% and folic acid
deficiency as 10% (12). These studies have reported
only rates in the elderly population. The present
study reflects a reliable stratified adult population in
Turkey with an age range of 18 to 92 years.
Megaloblastic anemia may cause psychiatric,
hematologic, and neurologic symptoms. Neurological
findings are the most unfortunate because they may
not regress despite appropriate therapy. Neurological
sequelae of B12 deficiency without anemia may occur.
Therefore, vitamin B12 deficiency should be treated
before macrocytosis is seen (12,13).
A common etiological classification of anemia
is that there are 3 main causative groups of anemia:
nutritional, marrow disease, and hemolytic.
Nutritional anemias, including iron, vitamin B12, and
folic acid deficiencies, are by far the most common
type of anemia worldwide. The other causes of anemia
are heavy blood loss as a result of menstruation, or
parasite infections such as hookworms, ascaris, and
962

schistosomiasis (4). Hemoglobin concentration is the
most reliable indicator of anemia at the population
level, as opposed to clinical measures, which are
subjective. In a recently published study from Turkey
the prevalence of anemia has been reported as 11.1%
and it has also been reported that 51.2% of the anemics
are microcytic, 45.5% are normocytic, and 3.3% are
macrocytic (14). In the present study, the crude
anemia rate was 25.8% in the general population and
46.9% of the anemics were microcytic (265 subjects),
52.6% were normocytic (297 subjects), and 0.5% were
macrocytic (only 3 subjects). The higher prevalence
of anemia in our study may be related to the fact that
the proportion of female subjects in our study (64%)
was higher than those in previous studies. However,
we found also that prevalence of anemia in males is
higher than those reported in previous studies.
The prevalence of iron deficiency anemia has
been reported before as 7.8% in Turkey (15). The
crude iron deficiency anemia rate was 6.9% in the
general population in the present study, which was
concordant with previously published data. Iron
deficiency anemia was more frequent in females and
increased as the number of births increased.
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Anemia is one of the most important health
problems in Turkey. Although many studies related
to anemia have been conducted, unfortunately the
number of comprehensive studies is almost negligible.
There is no homogeneity among the number and
age range of subjects in these studies. Some studies
included only patients who were hospitalized (16),
whereas others only included adolescents or school
children (17). Several others included patients
admitted to hospital for any reason (6), with pica
(18), pre-school children (16), or healthy volunteers
(5). Analytic methods also differ since in some studies
a complete blood count was used for diagnosis (14),
whereas more advanced diagnostic methods (serum
ferritin, iron, TSI%, etc.) were applied in others (15).

Anemia was shown to occur at all stages of life,
being more common in women and young children.
Anemia with vitamin B12 deficiency is more prevalent
in children and elderly subjects. Children, very
elderly subjects, and pregnant women were not
included in our study. In the present study a “realworld” adult cohort stratified for age and sex was
studied and the blood samples were taken in the
morning as recommended (19). Iron deficiency
anemics were also shown to consume less meat.
Depression was statistically more frequent in the
microcytic anemia group. Albacar et al. (20) reported
that iron plays a role in the etiology of postpartum
depression. The authors think that this topic needs
further investigation.
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